Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4005160 | American Journal of Ophthalmology | 2008 | 8 Pages |
Abstract
Methotrexate seems to be a well-tolerated therapy that can reduce inflammation successfully and can decrease the corticosteroid requirement in the treatment of chronic, noninfectious, and nonnecrotizing scleritis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Adrian W. Jachens, David S. Chu,